Detalles de la búsqueda
1.
Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study.
J Thromb Thrombolysis
; 2024 May 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38735015
2.
Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis.
Crit Care
; 26(1): 180, 2022 06 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35710578
3.
Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin.
Cardiovasc Diabetol
; 20(1): 52, 2021 02 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33637082
4.
Effectiveness and safety of rivaroxaban versus warfarin in obese patients with acute venous thromboembolism: analysis of electronic health record data.
J Thromb Thrombolysis
; 51(2): 349-358, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32588288
5.
Rivaroxaban versus apixaban in non-valvular atrial fibrillation patients with end-stage renal disease or receiving dialysis.
Eur J Haematol
; 104(4): 328-335, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31925840
6.
Rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism in African American patients: a retrospective cohort analysis.
Thromb J
; 18: 6, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32292291
7.
Comparative Effectiveness of Analgesics to Reduce Acute Pain in the Prehospital Setting.
Prehosp Emerg Care
; 24(2): 163-174, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31476930
8.
Comparative risk of major bleeding with rivaroxaban and warfarin: Population-based cohort study of unprovoked venous thromboembolism.
Eur J Haematol
; 102(2): 143-149, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30328143
9.
Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non-valvular atrial fibrillation and type 2 diabetes.
Diabetes Obes Metab
; 21(9): 2107-2114, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31099460
10.
External validation of three risk stratification rules in patients presenting with pulmonary embolism and cancer.
Support Care Cancer
; 27(3): 921-925, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30090992
11.
Safety and effectiveness of oral factor Xa inhibitors versus warfarin in nonvalvular atrial fibrillation patients at high-risk for falls.
J Thromb Thrombolysis
; 48(3): 366-372, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31228038
12.
The value of sPESI for risk stratification in patients with pulmonary embolism.
J Thromb Thrombolysis
; 48(1): 149-157, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30729377
13.
Effectiveness and Safety of Rivaroxaban in Patients With Cancer-Associated Venous Thrombosis.
J Natl Compr Canc Netw
; 16(5): 491-497, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29752323
14.
Response to the Letter by Spurling and Colleagues.
Crit Care
; 27(1): 65, 2023 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36804034
15.
Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism.
J Thromb Thrombolysis
; 46(3): 339-345, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29881958
16.
Meta-Analysis of Time in Therapeutic Range in Continuous-Flow Left Ventricular Assist Device Patients Receiving Warfarin.
Artif Organs
; 42(7): 700-704, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29508409
17.
Association of Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists With Asthma Control in Patients With Uncontrolled, Persistent Asthma: A Systematic Review and Meta-analysis.
JAMA
; 319(14): 1473-1484, 2018 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29554174
18.
Association of Inhaled Corticosteroids and Long-Acting ß-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis.
JAMA
; 319(14): 1485-1496, 2018 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29554195
19.
Comparative Effectiveness and Safety of Apixaban and Vitamin K Antagonist Therapy in Patients With Nonvalvular Atrial Fibrillation Treated in Routine German Practice.
Heart Lung Circ
; 27(3): 390-393, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28528780
20.
Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
Stroke
; 48(8): 2142-2149, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28655814